|
ES2293638T3
(es)
|
1994-03-25 |
2008-03-16 |
Isotechnika, Inc. |
Mejora de la eficacia de farmacos por deuteracion.
|
|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
US6534309B1
(en)
|
2000-08-03 |
2003-03-18 |
Cytokinetics, Inc. |
Motor proteins and methods for their use
|
|
CA2432825A1
(en)
|
2000-12-15 |
2002-06-20 |
Emory University |
Nonpeptide agonists and antagonists of vasopressin receptors
|
|
EP1517904A4
(en)
|
2002-05-23 |
2007-02-21 |
Merck & Co Inc |
INHIBITORS OF MITOTIC KINESINE
|
|
AU2003295600A1
(en)
|
2002-11-14 |
2004-06-15 |
Dharmacon, Inc. |
Functional and hyperfunctional sirna
|
|
US7423018B2
(en)
|
2002-12-13 |
2008-09-09 |
University Of Massachusetts |
Kinesin-like proteins and methods of use
|
|
WO2005017190A2
(en)
|
2003-08-15 |
2005-02-24 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
US7504413B2
(en)
|
2004-05-06 |
2009-03-17 |
Cytokinetics, Inc. |
N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
|
|
BRPI0510929A
(pt)
|
2004-06-18 |
2007-07-17 |
Chiron Corp |
derivados de n-(1-(1-benzil-4-fenil-1h-imidazol-2-il)-2,2-dimetilpropil) benzamida e compostos relacionados como inibidores de proteìna de eixo de kinesin (ksp) para o tratamento de cáncer
|
|
ATE486878T1
(de)
|
2004-08-18 |
2010-11-15 |
4Sc Ag |
Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin
|
|
WO2006114788A1
(en)
|
2005-04-25 |
2006-11-02 |
Ramot At Tel Aviv University Ltd. |
Kinesin polypeptides, polynucleotides encoding same and compositions and methods of using same
|
|
US20070135435A1
(en)
|
2005-11-02 |
2007-06-14 |
Xiangping Qian |
Certain chemical entities, compositions, and methods
|
|
EP2046330A2
(en)
|
2006-07-14 |
2009-04-15 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
WO2008015265A1
(de)
|
2006-08-04 |
2008-02-07 |
Æterna Zentaris Gmbh |
Anthracen-derivate und deren verwendung zur behandlung gutartiger und bösartiger tumorerkrankungen
|
|
US20080051463A1
(en)
|
2006-08-04 |
2008-02-28 |
Aeterna Zentaris Gmbh |
Anthracene compounds and their use for treating benign and malignant tumor disorders
|
|
TW201103904A
(en)
|
2009-06-11 |
2011-02-01 |
Hoffmann La Roche |
Janus kinase inhibitor compounds and methods
|
|
EP2295543A1
(en)
|
2009-09-11 |
2011-03-16 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Method for the preparation of an influenza virus
|
|
WO2011085261A1
(en)
|
2010-01-08 |
2011-07-14 |
Selexagen Therapeutics, Inc. |
Hedgehog inhibitors
|
|
JP5111626B2
(ja)
|
2011-01-14 |
2013-01-09 |
Ｎｔｎ株式会社 |
電動シートリクライニング用ころ軸受
|
|
CN102796103A
(zh)
|
2011-05-23 |
2012-11-28 |
南京英派药业有限公司 |
6-（芳基甲酰）咪唑并[1,2-a]嘧啶和6-（芳基甲酰）[1,2,4]三唑并[4,3-a]嘧啶作为Hedgehog抑制剂及其应用
|
|
US9890430B2
(en)
|
2012-06-12 |
2018-02-13 |
Washington University |
Copy number aberration driven endocrine response gene signature
|
|
JP6098406B2
(ja)
|
2013-07-17 |
2017-03-22 |
Ｊｆｅスチール株式会社 |
溶接接合部および溶接接合方法
|
|
PL3031799T3
(pl)
|
2013-08-09 |
2018-09-28 |
Takeda Pharmaceutical Company Limited |
Związek aromatyczny
|
|
JP2017517520A
(ja)
|
2014-05-29 |
2017-06-29 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
Ｗｅｅ１阻害剤を用いた癌を処置する方法
|
|
EP3233918A1
(en)
|
2014-12-19 |
2017-10-25 |
Novartis AG |
Combination therapies
|
|
WO2016168598A1
(en)
|
2015-04-17 |
2016-10-20 |
Forma Therapeutics, Inc. |
3-spirocyclic-6-hydroxamic acid tetralins as hdac inhibitors
|
|
CN106795149B
(zh)
|
2015-05-05 |
2019-09-24 |
上海海雁医药科技有限公司 |
双环取代的苯磺酰胺衍生物、其制法与医药上的用途
|
|
IL294183B2
(en)
|
2015-05-20 |
2023-10-01 |
Dana Farber Cancer Inst Inc |
shared neoantigens
|
|
JP7251981B2
(ja)
|
2016-03-24 |
2023-04-04 |
バイエル ファーマ アクチエンゲゼルシャフト |
酵素開裂基を有する細胞毒性活性剤のプロドラッグ
|
|
AU2018300007A1
(en)
|
2017-07-10 |
2020-02-27 |
Cornell University |
Targeting chromosomal instability and downstream cytosolic DNA signaling for cancer treatment
|
|
WO2019140380A1
(en)
|
2018-01-12 |
2019-07-18 |
Kymera Therapeutics, Inc. |
Protein degraders and uses thereof
|
|
CN108768023B
(zh)
|
2018-08-13 |
2020-01-07 |
珠海格力电器股份有限公司 |
转子组件及交替极电机
|
|
DE102018213662A1
(de)
|
2018-08-14 |
2020-02-20 |
Robert Bosch Gmbh |
Lautsprecher mit einem darin enthaltenen Leuchtelement
|
|
CN109039072B
(zh)
|
2018-08-21 |
2020-09-08 |
南京南瑞继保电气有限公司 |
一种双极双向直流变换器及其控制方法和控制装置
|
|
JP7686559B2
(ja)
|
2018-12-20 |
2025-06-02 |
アムジエン・インコーポレーテツド |
Ｋｉｆ１８ａ阻害剤
|
|
AU2019401495B2
(en)
|
2018-12-20 |
2025-06-26 |
Amgen Inc. |
Heteroaryl amides useful as KIF18A inhibitors
|
|
JP2022513967A
(ja)
|
2018-12-20 |
2022-02-09 |
アムジエン・インコーポレーテツド |
Ｋｉｆ１８ａ阻害剤として有用なヘテロアリールアミド
|
|
MA54543A
(fr)
*
|
2018-12-20 |
2022-03-30 |
Amgen Inc |
Inhibiteurs de kif18a
|
|
JP2022527629A
(ja)
|
2019-04-05 |
2022-06-02 |
アーリー・インコーポレイテッド |
合成バイオマーカーのための改良された方法及び組成物
|
|
WO2020226333A1
(ko)
|
2019-05-03 |
2020-11-12 |
주식회사 디시젠 |
암 예후 예측방법 및 이의 조성물
|
|
WO2021011634A1
(en)
|
2019-07-15 |
2021-01-21 |
Kymera Therapeutics, Inc. |
Protein degraders and uses thereof
|
|
EP4007752B1
(en)
|
2019-08-02 |
2025-09-24 |
Amgen Inc. |
Kif18a inhibitors
|
|
EP4007756B1
(en)
*
|
2019-08-02 |
2025-12-24 |
Amgen Inc. |
Kif18a inhibitors
|
|
EP4007638A1
(en)
|
2019-08-02 |
2022-06-08 |
Amgen Inc. |
Pyridine derivatives as kif18a inhibitors
|
|
EP4007753B1
(en)
|
2019-08-02 |
2025-09-24 |
Amgen Inc. |
Kif18a inhibitors
|
|
EP4103045A4
(en)
|
2020-02-16 |
2024-08-14 |
Genetikaplus Ltd. |
Methods of therapeutic prognostication
|
|
US12187992B2
(en)
|
2020-02-19 |
2025-01-07 |
The Regents Of The University Of California |
Method and device for early cancer screening
|
|
MX2022012992A
(es)
|
2020-04-14 |
2022-11-08 |
Amgen Inc |
Inhibidores de kif18a para el tratamiento de enfermedades neoplasicas.
|
|
US20230233565A1
(en)
|
2020-05-11 |
2023-07-27 |
University Of Vermont |
A treatment approach involving kif18a inhibition for chromosomally unstable tumors
|
|
KR20230050369A
(ko)
|
2020-08-07 |
2023-04-14 |
카스마 테라퓨틱스, 인코포레이티드 |
Trpml 조절제
|
|
US20240261425A1
(en)
|
2021-04-09 |
2024-08-08 |
Nanjing University |
Conjugate and the preparing method and use thereof
|
|
CN113528509A
(zh)
|
2021-06-01 |
2021-10-22 |
释科生物科技(广州)有限公司 |
一种用于预测胃癌免疫治疗的肿瘤微环境评分系统的构建方法以及分子探针
|
|
US20250214965A1
(en)
|
2021-06-25 |
2025-07-03 |
Hangzhou Innogate Pharma Co., Ltd. |
Compound as kif18a inhibitor
|
|
TW202321213A
(zh)
|
2021-07-21 |
2023-06-01 |
美商安進公司 |
Ｋｉｆ１８ａ抑制劑化合物之鹽和固態形式
|
|
CN115772159A
(zh)
|
2021-09-06 |
2023-03-10 |
微境生物医药科技(上海)有限公司 |
Kif18a抑制剂
|
|
CN115785068A
(zh)
|
2021-09-10 |
2023-03-14 |
微境生物医药科技(上海)有限公司 |
Kif18a抑制剂
|
|
WO2023041055A1
(zh)
|
2021-09-16 |
2023-03-23 |
微境生物医药科技(上海)有限公司 |
Kif18a抑制剂
|
|
US20230117405A1
(en)
|
2021-09-22 |
2023-04-20 |
Volastra Therapeutics, Inc. |
Systems and methods for evaluation of chromosomal instability using machine-learning
|
|
AU2022389558A1
(en)
|
2021-11-19 |
2024-05-23 |
Wigen Biomedicine Technology (shanghai) Co., Ltd. |
Kif18a inhibitor
|
|
JP2025515484A
(ja)
|
2022-04-28 |
2025-05-15 |
ヴォラストラ セラピューティクス，インコーポレーテッド |
Ｋｉｆ１８ａを阻害するための化合物
|